(Q39066974)

8 September 2017

title

Epigenetic and expression analysis of TRAIL-R2 and BCL2: on the TRAIL to knowledge of apoptosis in ovarian tumors (English)

1 reference

8 September 2017

author name string

Letícia da Conceição Braga

1

1 reference

8 September 2017

Luciana Maria Silva

2

1 reference

8 September 2017

Josiane Barbosa Piedade

3

1 reference

8 September 2017

Paulo Traiman

4

1 reference

8 September 2017

Agnaldo Lopes da Silva Filho

5

1 reference

8 September 2017

publication date

5 November 2013

1 reference

Archives of Gynecology and Obstetrics

8 September 2017

published in

1 reference

8 September 2017

volume

289

1 reference

8 September 2017

issue

5

1 reference

8 September 2017

page(s)

1061-1069

1 reference

https://scigraph.springernature.com/pub.10.1007/s00404-013-3060-0

8 September 2017

exact match

0 references

cites work

The biology of ovarian cancer: new opportunities for translation

1 reference

https://api.crossref.org/works/10.1007%2FS00404-013-3060-0

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-013-3060-0

Death receptors in chemotherapy and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-013-3060-0

The novel receptor TRAIL-R4 induces NF-kappaB and protects against TRAIL-mediated apoptosis, yet retains an incomplete death domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-013-3060-0

Cloning and characterization of TRAIL-R3, a novel member of the emerging TRAIL receptor family

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-013-3060-0

Epigenetic silencing of death receptor 4 mediates tumor necrosis factor-related apoptosis-inducing ligand resistance in gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-013-3060-0

Apoptosis: a review of programmed cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-013-3060-0

Analysis of death receptor 5 and caspase-8 expression in primary and metastatic head and neck squamous cell carcinoma and their prognostic impact

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-013-3060-0

TRAIL signalling: decisions between life and death.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-013-3060-0

Role of mitochondria in toxic oxidative stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-013-3060-0

Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-013-3060-0

BCL-2 modifying factor (BMF) is a central regulator of anoikis in human intestinal epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-013-3060-0

The biochemistry of apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-013-3060-0

Ovarian cancer: linking genomics to new target discovery and molecular markers--the way ahead

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-013-3060-0

Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-013-3060-0

Silencing of death receptor and caspase-8 expression in small cell lung carcinoma cell lines and tumors by DNA methylation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-013-3060-0

Death and anti-death: tumour resistance to apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-013-3060-0

Methylation and expression analysis of 15 genes and three normally-methylated genes in 13 Ovarian cancer cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-013-3060-0

Deficient tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) death receptor transport to the cell surface in human colon cancer cells selected for resistance to TRAIL-induced apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-013-3060-0

Doxorubicin pretreatment sensitizes prostate cancer cell lines to TRAIL induced apoptosis which correlates with the loss of c-FLIP expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-013-3060-0

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-013-3060-0

Death receptors: targets for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-013-3060-0

TRAIL resistance results in cancer progression: a TRAIL to perdition?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-013-3060-0

21 January 2018

TRAILing death in cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00404-013-3060-0

Glucocorticoid receptor antagonist sensitizes TRAIL-induced apoptosis in renal carcinoma cells through up-regulation of DR5 and down-regulation of c-FLIP(L) and Bcl-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-013-3060-0

The sensors and regulators of cell-matrix surveillance in anoikis resistance of tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-013-3060-0

An antagonist decoy receptor and a death domain-containing receptor for TRAIL

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-013-3060-0

Towards novel paradigms for cancer therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-013-3060-0

Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-013-3060-0

Aberrant methylation of trail decoy receptor genes is frequent in multiple tumor types

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-013-3060-0

Anoikis: an emerging hallmark in health and diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-013-3060-0

Apoptosis: controlled demolition at the cellular level

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-013-3060-0

Gene silencing in mammalian cells and the spread of DNA methylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-013-3060-0

TRAIL-R2: a novel apoptosis-mediating receptor for TRAIL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-013-3060-0

A PCR primer bank for quantitative gene expression analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-013-3060-0

Beyond chemotherapy: targeted therapies in ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-013-3060-0

The therapeutic potential of TRAIL receptor signalling in cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-013-3060-0

An apoptotic molecular network identified by microarray: On the TRAIL to new insights in epithelial ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-013-3060-0

10.1007/S00404-013-3060-0

21 January 2018

Identifiers

DOI

1 reference

8 September 2017

1 reference